awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39448172-ACE1EBC1-FDB8-47B4-B92D-8211F0EF3DB1
Q39448172-ACE1EBC1-FDB8-47B4-B92D-8211F0EF3DB1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39448172-ACE1EBC1-FDB8-47B4-B92D-8211F0EF3DB1
Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures.
P2860
Q39448172-ACE1EBC1-FDB8-47B4-B92D-8211F0EF3DB1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39448172-ACE1EBC1-FDB8-47B4-B92D-8211F0EF3DB1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ac57a376a53f7f5c031673103383c0a8523095de
P2860
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.